You have 3 free guides left 😟
Unlock your guides
You have 3 free guides left 😟
Unlock your guides

19.3 Metabolic Disorders and Diseases

3 min readaugust 9, 2024

Metabolic disorders disrupt the body's ability to process nutrients and energy. From diabetes to inborn errors of metabolism, these conditions highlight the intricate balance of biochemical pathways essential for health.

Understanding metabolic diseases reveals the interconnectedness of our body's systems. By examining how these disorders affect energy production and nutrient processing, we gain insights into the complex network of metabolic pathways and their regulation.

Metabolic Disorders

Diabetes Mellitus and Obesity

Top images from around the web for Diabetes Mellitus and Obesity
Top images from around the web for Diabetes Mellitus and Obesity
  • disrupts glucose metabolism due to insufficient insulin production or
    • results from autoimmune destruction of pancreatic β-cells
    • involves decreased insulin sensitivity in target tissues
  • develops from chronic energy imbalance leading to excess fat accumulation
    • (BMI) ≥ 30 kg/m² indicates obesity
    • Contributes to insulin resistance and increases risk of type 2 diabetes
  • Both conditions involve dysregulation of energy homeostasis and metabolism
  • Long-term complications include cardiovascular disease, neuropathy, and nephropathy

Metabolic Syndrome and Ketoacidosis

  • comprises a cluster of conditions increasing cardiovascular risk
    • Includes abdominal obesity, hypertension, dyslipidemia, and insulin resistance
    • Diagnosis requires presence of at least three components
  • occurs when the body breaks down fatty acids for energy instead of glucose
    • Produces (acetoacetate, β-hydroxybutyrate, acetone)
    • Can lead to dangerously low blood pH (acidosis)
    • Common in uncontrolled type 1 diabetes or severe insulin deficiency
  • Both conditions reflect severe metabolic imbalances requiring prompt medical intervention

Inborn Errors of Metabolism

Phenylketonuria and Glycogen Storage Diseases

  • (PKU) results from deficiency in enzyme
    • Leads to accumulation of phenylalanine and its metabolites in blood and tissues
    • Causes intellectual disability if left untreated
    • Managed through dietary restriction of phenylalanine
  • involve defects in glycogen synthesis or breakdown
    • Type I (von Gierke's disease) lacks
    • Type II (Pompe's disease) lacks
    • Symptoms vary but often include , , and muscle weakness
  • Both disorders highlight the importance of early detection through newborn screening

Fatty Acid Oxidation Disorders and Mitochondrial Diseases

  • impair the breakdown of fatty acids for energy
    • Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency most common
    • Symptoms include hypoglycemia, lethargy, and seizures during fasting or illness
  • affect cellular energy production
    • Can result from mutations in mitochondrial or nuclear DNA
    • causes vision loss
    • , , and (MELAS) syndrome affects multiple organ systems
  • Both groups of disorders underscore the critical role of mitochondria in metabolism

Other Metabolic Diseases

Gout and Hyperuricemia

  • results from elevated uric acid levels in the blood ()
    • Uric acid crystals deposit in joints causing inflammation and severe pain
    • Commonly affects the big toe ()
    • Risk factors include diet high in purines (red meat, organ meats), alcohol consumption
  • Hyperuricemia occurs when uric acid production exceeds excretion
    • Normal uric acid levels: 3.5-7.2 mg/dL in men, 2.6-6.0 mg/dL in women
    • Can lead to kidney stones and chronic kidney disease if untreated
  • Management involves dietary modifications, medications to reduce uric acid production or increase excretion

Hyperlipidemia and Hypercholesterolemia

  • refers to elevated levels of lipids (fats) in the blood
    • Includes elevated and cholesterol
    • Can be primary (genetic) or secondary (due to other conditions or lifestyle factors)
  • specifically involves high blood cholesterol levels
    • LDL cholesterol ≥ 130 mg/dL considered high
    • caused by genetic defects in LDL receptor function
  • Both conditions increase risk of atherosclerosis and cardiovascular disease
    • Treatment includes lifestyle changes (diet, exercise) and medications (statins)
  • Regular lipid profile monitoring essential for early detection and management
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Glossary
Glossary